This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M Ng , T Fleming , M Robinson , et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384, 766–781.
P Hossain , B Kawar , M El Nahas . Obesity and diabetes in the developing world – a growing challenge. N Engl J Med. 2007; 356, 213–215.
AH Mokdad , ES Ford , BA Bowman , et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289, 76–79.
RM Wilson , I Messaoudi . The impact of maternal obesity during pregnancy on offspring immunity. Mol Cell Endocrinol. 2015; 418, 134–142.
NJ Sebire , M Jolly , J Harris , et al. Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London. Int J Obes (Lond). 2001; 25, 1175–1182.
PM Catalano , HM Ehrenberg . The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006; 113, 1126–1133.
RC Whitaker . Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics. 2004; 114, e29–e36.
CM Boney , A Verma , R Tucker , et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005; 115, e290–e296.
Z Yu , S Han , J Zhu , et al. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLoS One. 2013; 8, e61627.
M Vickers . Developmental programming and transgenerational transmission of obesity. Ann Nutr Metab. 2014; 64, 26–34.
JR O’Reilly , RM Reynolds . The risk of maternal obesity to the long‐term health of the offspring. Clin Endocrinol (Oxf). 2013; 78, 9–16.
JE Ramsay , WR Ferrell , L Crawford , et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocr Metab. 2002; 87, 4231–4237.
CN Lumeng , AR Saltiel . Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011; 121, 2111–2117.
CN Lumeng , JL Bodzin , AR Saltiel . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117, 175–184.
R Drolet , C Bélanger , M Fortier , et al. Fat depot‐specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity. 2009; 17, 424–430.
JK Kim , O Gavrilova , Y Chen , et al. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem. 2000; 275, 8456–8460.
J Ye , Z Gao , J Yin , et al. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007; 293, E1118–E1128.
JN Fain . Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006; 74, 443–477.
JV Silha , M Krsek , JV Skrha , et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003; 149, 331–335.
RP Wildman , P Muntner , K Reynolds , et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168, 1617–1624.
M Mongraw-Chaffin , MC Foster , RR Kalyani , et al. Obesity severity and duration are associated with incident metabolic syndrome: evidence against metabolically healthy obesity from the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2016; 101, 4117–4124.
GM Hinnouho , S Czernichow , A Dugravot , et al. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?
Diabetes Care. 2013; 36, 2294–2300.
GS Hotamisligil , NS Shargill , BM Spiegelman . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259, 87–91.
GS Hotamisligil , P Arner , JF Caro , et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995; 95, 2409–2415.
X Chen , K Xun , L Chen , et al. TNF‐α, a potent lipid metabolism regulator. Cell Biochem Funct. 2009; 27, 407–416.
C Lagathu , L Yvan-Charvet , J Bastard , et al. Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes. Diabetologia. 2006; 49, 2162–2173.
FC McGillicuddy , KA Harford , CM Reynolds , et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes. 2011; 60, 1688–1698.
J Kim , RA Bachmann , J Chen . Interleukin‐6 and insulin resistance. Vitam Horm. 2009; 80, 613–633.
V Mohamed-Ali , S Goodrick , A Rawesh , et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo 1. J Clin Endocrinol Metab. 1997; 82, 4196–4200.
V Rotter , I Nagaev , U Smith . Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003; 278, 45777–45784.
JJ Senn , PJ Klover , IA Nowak , et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002; 51, 3391–3399.
BK Pedersen , A Steensberg , P Schjerling . Muscle‐derived interleukin‐6: possible biological effects. J Physiol (Lond). 2001; 536, 329–337.
FB Hu , JB Meigs , TY Li , et al. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53, 693–700.
V Matthews , T Allen , S Risis , et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia. 2010; 53, 2431–2441.
E van Exel , J Gussekloo , AJ de Craen , et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes. 2002; 51, 1088–1092.
L Belo , A Santos-Silva , S Rocha , et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005; 123, 46–51.
L Zhang , T Sugiyama , N Murabayashi , et al. The inflammatory changes of adipose tissue in late pregnant mice. J Mol Endocrinol. 2011; 47, 157–165.
JC Madan , JM Davis , WY Craig , et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine. 2009; 47, 61–64.
R Retnakaran , AJ Hanley , N Raif , et al. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003; 88, 3507–3512.
S Basu , M Haghiac , P Surace , et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity. 2011; 19, 476–482.
S Arenz , R Rückerl , B Koletzko , et al. Breast-feeding and childhood obesity – a systematic review. Int J Obes. 2004; 28, 1247–1256.
P Morigny , M Houssier , E Mouisel , et al. Adipocyte lipolysis and insulin resistance. Biochimie. 2016; 125, 259–266.
E Zambrano , PW Nathanielsz . Mechanisms by which maternal obesity programs offspring for obesity: evidence from animal studies. Nutr Rev. 2013; 71(Suppl. 1), S42–S54.
M Tschop , C Weyer , PA Tataranni , et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001; 50, 707–709.
G Collden , E Balland , J Parkash , et al. Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin. Mol Metab. 2015; 4, 15–24.
SY Huh , SL Rifas-Shiman , EM Taveras , et al. Timing of solid food introduction and risk of obesity in preschool-aged children. Pediatrics. 2011; 127, e544–e551.
T Radaelli , J Uvena-Celebrezze , J Minium , et al. Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig. 2006; 13, 53–57.
R Gaillard , SL Rifas‐Shiman , W Perng , et al. Maternal inflammation during pregnancy and childhood adiposity. Obesity. 2016; 24, 1320–1327.
N Farah , AE Hogan , N O’Connor , et al. Correlation between maternal inflammatory markers and fetomaternal adiposity. Cytokine. 2012; 60, 96–99.
E Toledo Baldi , V Dias Bóbbo , M Melo Lima , et al. Tumor necrosis factor‐alpha levels in blood cord is directly correlated with the body weight of mothers. Obes Sci Pract. 2016; 2, 210–214.
I Danielsen , C Granström , D Rytter , et al. Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring. Obesity. 2014; 22, 1351–1358.
CE Onore , JJ Schwartzer , M Careaga , et al. Maternal immune activation leads to activated inflammatory macrophages in offspring. Brain Behav Immun. 2014; 38, 220–226.
TB Kirsten , LL Lippi , E Bevilacqua , et al. LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Beta levels in adult rat offspring: relevance to autism. PLoS One. 2013; 8, e82244.
C Nilsson , B Larsson , E Jennische , et al. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring 1. Endocrinology. 2001; 142, 2622–2630.
N Murabayashi , T Sugiyama , L Zhang , et al. Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. Eur J Obstet Gyn R B. 2013; 169, 39–44.
MZ Alfaradhi , LC Kusinski , DS Fernandez-Twinn , et al. Maternal obesity in pregnancy developmentally programs adipose tissue inflammation in young, lean male mice offspring. Endocrinology. 2016; 157, 4246–4256.
JC Challier , S Basu , T Bintein , et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008; 29, 274–281.
MJ Zhu , M Du , PW Nathanielsz , et al. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta. 2010; 31, 387–391.
JL Halaas , KS Gajiwala , M Maffei , et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269, 543–546.
M Lappas , M Permezel , GE Rice . Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology. 2005; 146, 3334–3342.
MW Schwartz , E Peskind , M Raskind , et al. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med. 1996; 2, 589–593.
JA Oben , A Mouralidarane , AM Samuelsson , et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol. 2010; 52, 913–920.
N Sáinz , CJ González-Navarro , JA Martínez , et al. Leptin signaling as a therapeutic target of obesity. Expert Opin Ther Targets. 2015; 19, 893–909.
K Park , KS Park , M Kim , et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract. 2004; 63, 135–142.
T Yamauchi , J Kamon , Ya Minokoshi , et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8, 1288–1295.
K Ohashi , JL Parker , N Ouchi , et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010; 285, 6153–6160.
HN Jones , LA Woollett , N Barbour , et al. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009; 23, 271–278.
IL Aye , FJ Rosario , TL Powell , et al. Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth. Proc Natl Acad Sci U S A. 2015; 112, 12858–12863.
J Saben , F Lindsey , Y Zhong , et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta. 2014; 35, 171–177.
NC Dosch , EF Guslits , MB Weber , et al. Maternal obesity affects inflammatory and iron indices in umbilical cord blood. J Pediatr. 2016; 172, 20–28.
L Kroener , ET Wang , MD Pisarska . Predisposing factors to abnormal first trimester placentation and the impact on fetal outcomes. Semin Reprod Med. 2016; 34, 27–35.
EK Hayes , DR Tessier , ME Percival , et al. Trophoblast invasion and blood vessel remodeling are altered in a rat model of lifelong maternal obesity. Reprod Sci. 2014; 21, 648–657.
S Lager , N Jansson , A Olsson , et al. Effect of IL-6 and TNF-α on fatty acid uptake in cultured human primary trophoblast cells. Placenta. 2011; 32, 121–127.
P Mark , J Lewis , M Jones , et al. The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone. Placenta. 2013; 34, 559–566.
D Farley , J Choi , D Dudley , et al. Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta. 2010; 31, 718–724.
SM Leon-Garcia , HA Roeder , KK Nelson , et al. Maternal obesity and sex-specific differences in placental pathology. Placenta. 2016; 38, 33–40.
E Dube , A Gravel , C Martin , et al. Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta. Biol Reprod. 2012; 87, 1–11.
MA Hanson , PD Gluckman . Early developmental conditioning of later health and disease: physiology or pathophysiology?
Physiol Rev. 2014; 94, 1027–1076.
AM Petersen , BK Pedersen . The anti-inflammatory effect of exercise.
J Appl Physiol (1985). 2005; 98, 1154–1162.
ES Ford . Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology. 2002; 13, 561–568.
I Bae-Gartz , R Janoschek , CS Kloppe , et al. Running exercise in obese pregnancies prevents IL-6 trans-signaling in male offspring. Med Sci Sports Exerc. 2016; 48, 829–838.
RA Tinius , AG Cahill , EA Strand , et al. Maternal inflammation during late pregnancy is lower in physically active compared with inactive obese women. Appl Physiol Nutr Metab. 2015; 41, 191–198.
H Chen , D Simar , K Pegg , et al. Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents. Diabetologia. 2014; 57, 614–622.
M Heliövaara , M Herz , A Teppo , et al. Pioglitazone has anti-inflammatory effects in patients with type 2 diabetes. J Endocrinol Invest. 2007; 30, 292–297.
A Kalanderian , N Abate , I Patrikeev , et al. Pioglitazone therapy in mouse offspring exposed to maternal obesity. Am J Obstet Gynecol. 2013; 208, 308 e1–7.
N Desai , A Roman , B Rochelson , et al. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. Am J Obstet Gynecol. 2013; 209, 136.e1–9.
K Harris , N Desai , M Gupta , et al. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutr Metab (Lond). 2016; 13, 55.
H Salomäki , M Heinäniemi , LH Vähätalo , et al. Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring. PLoS One. 2014; 9, e115778.
CA Chiswick , RM Reynolds , FC Denison , et al. Efficacy of metformin in pregnant obese women: a randomised controlled trial. BMJ Open. 2015; 5, e006854.
C Chiswick , RM Reynolds , F Denison , et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015; 3, 778–786.
TE Novak , TA Babcock , DH Jho , et al. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003; 284, L84–L89.
S Neschen , K Morino , JC Rossbacher , et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes. 2006; 55, 924–928.
M Haghiac , X Yang , L Presley , et al. Dietary omega-3 fatty acid supplementation reduces inflammation in obese pregnant women: a randomized double-blind controlled clinical trial. PLoS One. 2015; 10, e0137309.
S Melody , R Vincent , T Mori , et al. Effects of omega-3 and omega-6 fatty acids on human placental cytokine production. Placenta. 2015; 36, 34–40.
R Moon , N Harvey , S Robinson , et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab. 2012; 98, 299–307.
C Brei , L Stecher , D Much , et al. Reduction of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring body composition: follow-up results from a randomized controlled trial up to 5 y of age. Am J Clin Nutr. 2016; 103, 1472–1481.
N Stratakis , M Gielen , L Chatzi , et al. Effect of maternal n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on adiposity in childhood: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2014; 68, 1277–1287.
AP Simopoulos . The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002; 56, 365–379.
AP Simopoulos . An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016; 8, 128.
MJ Heerwagen , MS Stewart , BA de la Houssaye , et al. Transgenic increase in n-3/n-6 fatty acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice. PLoS One. 2013; 8, e67791.
HN Bagley , Y Wang , MS Campbell , et al. Maternal docosahexaenoic acid increases adiponectin and normalizes IUGR-induced changes in rat adipose deposition. J Obes. 2013; 2013, 312153.
BS Muhlhausler , D Miljkovic , L Fong , et al. Maternal omega-3 supplementation increases fat mass in male and female rat offspring. Front Genet. 2011; 2, 48.
IS Zulkafli , BJ Waddell , PJ Mark . Postnatal dietary omega-3 fatty acid supplementation rescues glucocorticoid-programmed adiposity, hypertension, and hyperlipidemia in male rat offspring raised on a high-fat diet. Endocrinology. 2013; 154, 3110–3117.
PJ Mark , CS Wyrwoll , IS Zulkafli , et al. Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat. Reprod Biol Endocrinol. 2014; 12, 1.
A Chicco , A Creus , P Illesca , et al. Effects of post-suckling n-3 polyunsaturated fatty acids: prevention of dyslipidemia and liver steatosis induced in rats by a sucrose-rich diet during pre-and post-natal life. Food Funct. 2016; 7, 445–454.
KA Balogun , SK Cheema . Dietary omega-3 fatty acids prevented adipocyte hypertrophy by downregulating DGAT-2 and FABP-4 in a sex-dependent fashion. Lipids. 2016; 51, 25–38.
B Muhlhausler , R Gibson , M Makrides . The effect of maternal omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation during pregnancy and/or lactation on body fat mass in the offspring: a systematic review of animal studies. Prostaglandins Leukot Essent Fatty Acids. 2011; 85, 83–88.
LV Mennitti , JL Oliveira , CA Morais , et al. Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring. J Nutr Biochem. 2015; 26, 99–111.
A Kennedy , K Martinez , S Schmidt , et al. Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem. 2010; 21, 171–179.
D Bauman , L Baumgard , B Corl , et al. Biosynthesis of conjugated linoleic acid in ruminants. J Anim Sci. 2000; 77, 1–15.
M Viladomiu , R Hontecillas , J Bassaganya-Riera . Modulation of inflammation and immunity by dietary conjugated linoleic acid. Eur J Pharmacol. 2015; 785, 87–95.
TR Dhiman , S Nam , AL Ure . Factors affecting conjugated linoleic acid content in milk and meat. Crit Rev Food Sci Nutr. 2005; 45, 463–482.
KL Houseknecht , JPV Heuvel , SY Moya-Camarena , et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998; 244, 678–682.
D Kritchevsky , SA Tepper , S Wright , et al. Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr Res. 2002; 22, 1275–1279.
F Moloney , S Toomey , E Noone , et al. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes. 2007; 56, 574–582.
J Bassaganya-Riera , K Reynolds , S Martino-Catt , et al. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology. 2004; 127, 777–791.
MA Belury , SY Moya-Camarena , M Lu , et al. Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-gamma (PPAR gamma). Nutr Res. 2002; 22, 817–824.
W Cheng , C Lii , H Chen , et al. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-κB pathway. J Agric Food Chem. 2004; 52, 71–78.
CM Reynolds , CE Loscher , AP Moloney , et al. Cis-9, trans-11-conjugated linoleic acid but not its precursor trans-vaccenic acid attenuate inflammatory markers in the human colonic epithelial cell line Caco-2. Br J Nutr. 2008; 100, 13–17.
CM Reynolds , E Draper , B Keogh , et al. A conjugated linoleic acid-enriched beef diet attenuates lipopolysaccharide-induced inflammation in mice in part through PPARgamma-mediated suppression of toll-like receptor 4. J Nutr. 2009; 139, 2351–2357.
Y Park , JM Storkson , KJ Albright , et al. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999; 34, 235–241.
SA Segovia , MH Vickers , XD Zhang , et al. Maternal supplementation with conjugated linoleic acid in the setting of diet-induced obesity normalises the inflammatory phenotype in mothers and reverses metabolic dysfunction and impaired insulin sensitivity in offspring. J Nutr Biochem. 2015; 26, 1448–1457.